Literature DB >> 31879556

Soluble Urokinase Receptor and Liver Disease.

Changli Wei1, Ke Zhu1, Jochen Reiser1.   

Abstract

Entities:  

Year:  2019        PMID： 31879556      PMCID： PMC6924968          DOI： 10.1002/cld.850

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  22 in total

1.  Soluble urokinase plasminogen activator receptor is associated with progressive liver fibrosis in hepatitis C infection.

Authors:  Marie-Luise Berres; Beate Schlosser; Thomas Berg; Christian Trautwein; Hermann E Wasmuth
Journal:  J Clin Gastroenterol       Date:  2012-04       Impact factor: 3.062

2.  c-Src is in the effector pathway linking uPAR and podocyte injury.

Authors:  Jeffrey B Kopp; Jurgen Heymann
Journal:  J Clin Invest       Date:  2019-04-02       Impact factor: 14.808

3.  Soluble Urokinase Plasminogen Activator Receptor and Decline in Kidney Function in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Salim S Hayek; Douglas P Landsittel; Changli Wei; Martin Zeier; Alan S L Yu; Vicente E Torres; Sharin Roth; Christina S Pao; Jochen Reiser
Journal:  J Am Soc Nephrol       Date:  2019-06-06       Impact factor: 10.121

4.  Serum soluble urokinase plasminogen activator receptor as a screening test for the early diagnosis of hepatocellular carcinoma.

Authors:  Athina Chounta; Christofer Ellinas; Vassiliki Tzanetakou; Fani Pliarhopoulou; Virginia Mplani; Angelos Oikonomou; Kostantinos Leventogiannis; Evangelos J Giamarellos-Bourboulis
Journal:  Liver Int       Date:  2014-11-20       Impact factor: 5.828

Review 5.  SuPAR, an emerging biomarker in kidney and inflammatory diseases.

Authors:  Lamiaa Hamie; Georges Daoud; Georges Nemer; Tarek Nammour; Alissar El Chediak; Imad W Uthman; Abdul Ghani Kibbi; Assaad Eid; Mazen Kurban
Journal:  Postgrad Med J       Date:  2018-09-03       Impact factor: 2.401

6.  Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure.

Authors:  Alexander Koch; Henning W Zimmermann; Nikolaus Gassler; Christoph Jochum; Ralf Weiskirchen; Jan Bruensing; Lukas Buendgens; Hanna Dückers; Tony Bruns; Guido Gerken; Ulf P Neumann; David H Adams; Christian Trautwein; Ali Canbay; Frank Tacke
Journal:  Liver Int       Date:  2014-03-19       Impact factor: 5.828

7.  Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B.

Authors:  Huanqin Zhou; Xianguo Wu; Xingguo Lu; Gang Chen; Xiongwei Ye; Jian Huang
Journal:  Thromb Res       Date:  2008-08-08       Impact factor: 3.944

8.  Serum soluble urokinase-type plasminogen activator receptor and interferon-γ-induced protein 10 levels correlate with significant fibrosis in chronic hepatitis B.

Authors:  Dilek Yıldız Sevgi; Banu Bayraktar; Alper Gündüz; Banu Yılmaz Özgüven; Alper Togay; Emin Bulut; Nuray Uzun; İlyas Dökmetaş
Journal:  Wien Klin Wochenschr       Date:  2015-11-06       Impact factor: 1.704

9.  Modification of kidney barrier function by the urokinase receptor.

Authors:  Changli Wei; Clemens C Möller; Mehmet M Altintas; Jing Li; Karin Schwarz; Serena Zacchigna; Liang Xie; Anna Henger; Holger Schmid; Maria P Rastaldi; Peter Cowan; Matthias Kretzler; Roberto Parrilla; Moïse Bendayan; Vineet Gupta; Boris Nikolic; Raghu Kalluri; Peter Carmeliet; Peter Mundel; Jochen Reiser
Journal:  Nat Med       Date:  2007-12-16       Impact factor: 53.440

10.  Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease.

Authors:  Eunsil Hahm; Changli Wei; Isabel Fernandez; Jing Li; Nicholas J Tardi; Melissa Tracy; Shikha Wadhwani; Yanxia Cao; Vasil Peev; Andrew Zloza; Jevgenijs Lusciks; Salim S Hayek; Christopher O'Connor; Markus Bitzer; Vineet Gupta; Sanja Sever; David B Sykes; David T Scadden; Jochen Reiser
Journal:  Nat Med       Date:  2016-12-12       Impact factor: 53.440
View more
  1 in total

1.  Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated with Severity of Fibrosis in Patients with Primary Sclerosing Cholangitis.

Authors:  Burcin Özdirik; Martin Maibier; Maria Scherf; Jule Marie Nicklaus; Josephine Frohme; Tobias Puengel; Dirk Meyer Zum Büschenfelde; Frank Tacke; Tobias Mueller; Michael Sigal
Journal:  J Clin Med       Date:  2022-04-28       Impact factor: 4.964
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.